Clinical Trials in San Francisco

Showing 3721-3740 of 12,991 trials

PRescription Exercise for Older Men With Urinary Disease

NCT06225479

This is a single-center pilot randomized controlled trial among 68 physically "inactive" older men with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (LUTS/BPH) assessing a 12-week remote exercise intervention versus health education control.

Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia

University of California, San Francisco68 participantsStarted Jan 2024

San Francisco, California, United States • San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

NCT02492711

The purpose of this study is to determine whether patients with metastatic breast cancer treated with margetuximab plus chemotherapy have longer progression free survival (PFS) and overall survival (OS) than patients treated with trastuzumab plus chemotherapy. A non-randomized sub-study cohort of approximately 88 patients will be enrolled to evaluate the safety of a reduced margetuximab infusion rate in patients receiving margetuximab either as monotherapy or in combination with chemotherapy.

HER-2 Positive Breast CancerMetastatic Neoplasm

MacroGenics624 participantsStarted Aug 2015

Chandler, Arizona, United States • Gilbert, Arizona, United States • Goodyear, Arizona, United States +164 more locations

PRescription Exercise for Older Men With Urinary Disease

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

Find Trials by Condition in San Francisco

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia

Infant Mortality Reduction by the Mass Administration of Azithromycin

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

Observational Study to Evaluate the STALIF® C FLX, STALIF® M FLX, STALIF® L FLX Cages and FORTOS-C®

APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)

Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients

Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde Cholangiopancreatography).

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

Brain Injury Rehabilitation Improving the Transition Experience